MDxHealth (MDXH) Return on Sales (2021 - 2026)

MDxHealth (MDXH) has 6 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales improved to 0.0% in Q1 2026 per MDXH's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 29.7% in Q2 2022, with the low at 0.01% in Q1 2022.
• Average Return on Sales over 5 years is 1.74%, with a median of 0.0% recorded in 2024.
• The widest YoY moves for Return on Sales: up 1 bps in 2023, down 2970 bps in 2023.
• MDxHealth's Return on Sales stood at 0.01% in 2022, then soared by 42 bps to 0.01% in 2023, then soared by 51 bps to 0.0% in 2024, then slumped by 50 bps to 0.0% in 2025, then grew by 21 bps to 0.0% in 2026.
• Business Quant data shows MDXH's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.